Cancer Immunotherapy Biomarker Profiling Assay

There is increasing evidence suggesting that the number, type, and location of tumor-infiltrating lymphocytes in primary tumors harbor prognostic value, and this has led to the development of a “tumor immunoscore / immune” index. The aim of this study was to perform molecular profiling of key immune-related genes, including drug targets, known biomarkers, and immune mechanisms to discover informative biomarkers that can be analyzed by conventional IHC/FACS assays.